467 related articles for article (PubMed ID: 25585167)
1. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
Amminger GP; Mechelli A; Rice S; Kim SW; Klier CM; McNamara RK; Berk M; McGorry PD; Schäfer MR
Transl Psychiatry; 2015 Jan; 5(1):e495. PubMed ID: 25585167
[TBL] [Abstract][Full Text] [Related]
2. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
[TBL] [Abstract][Full Text] [Related]
3. Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis.
Lavoie S; Whitford TJ; Benninger F; Feucht M; Kim SW; Klier CM; McNamara RK; Rice S; Schäfer MR; Amminger GP
Aust N Z J Psychiatry; 2016 Jan; 50(1):56-63. PubMed ID: 25690743
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.
Amminger GP; Chanen AM; Ohmann S; Klier CM; Mossaheb N; Bechdolf A; Nelson B; Thompson A; McGorry PD; Yung AR; Schäfer MR
Can J Psychiatry; 2013 Jul; 58(7):402-8. PubMed ID: 23870722
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis.
Collins M; Bartholomeusz C; Mei C; Kerr M; Spark J; Wallis N; Polari A; Baird S; Buccilli K; Dempsey SA; Ferguson N; Formica M; Krcmar M; Quinn AL; Wannan C; Oldham S; Fornito A; Mebrahtu Y; Ruslins A; Street R; Loschiavo K; McGorry PD; Nelson B; Amminger GP
Psychiatry Res; 2024 Jul; 337():115966. PubMed ID: 38810536
[TBL] [Abstract][Full Text] [Related]
8. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.
Armando M; De Crescenzo F; Vicari S; Digilio MC; Pontillo M; Papaleo F; Amminger GP
Early Interv Psychiatry; 2016 Oct; 10(5):390-6. PubMed ID: 25345540
[TBL] [Abstract][Full Text] [Related]
9. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
11. Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.
Smesny S; Milleit B; Schaefer MR; Hipler UC; Milleit C; Wiegand C; Hesse J; Klier CM; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
Prostaglandins Leukot Essent Fatty Acids; 2015 Oct; 101():15-21. PubMed ID: 26260538
[TBL] [Abstract][Full Text] [Related]
12. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.
Markulev C; McGorry PD; Nelson B; Yuen HP; Schaefer M; Yung AR; Thompson A; Berger G; Mossaheb N; Schlögelhofer M; Smesny S; de Haan L; Riecher-Rössler A; Nordentoft M; Chen EYH; Verma S; Hickie I; Amminger GP
Early Interv Psychiatry; 2017 Oct; 11(5):418-428. PubMed ID: 26279065
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study.
Kim SW; Jhon M; Kim JM; Smesny S; Rice S; Berk M; Klier CM; McGorry PD; Schäfer MR; Amminger GP
PLoS One; 2016; 11(3):e0151417. PubMed ID: 26963912
[TBL] [Abstract][Full Text] [Related]
14. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men.
Safarinejad MR; Hosseini SY; Dadkhah F; Asgari MA
Clin Nutr; 2010 Feb; 29(1):100-5. PubMed ID: 19666200
[TBL] [Abstract][Full Text] [Related]
15. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats.
Tu WC; Mühlhäusler BS; Yelland LN; Gibson RA
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):53-60. PubMed ID: 22521090
[TBL] [Abstract][Full Text] [Related]
16. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
Berger ME; Smesny S; Kim SW; Davey CG; Rice S; Sarnyai Z; Schlögelhofer M; Schäfer MR; Berk M; McGorry PD; Amminger GP
Transl Psychiatry; 2017 Aug; 7(8):e1220. PubMed ID: 28850110
[TBL] [Abstract][Full Text] [Related]
17. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Alqarni A; Mitchell TW; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP; Meyer BJ
Schizophr Res; 2020 Dec; 226():44-51. PubMed ID: 31301881
[TBL] [Abstract][Full Text] [Related]
18. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
[TBL] [Abstract][Full Text] [Related]
19. Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.
An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Park Y
Prostaglandins Leukot Essent Fatty Acids; 2012; 86(1-2):29-34. PubMed ID: 22071008
[TBL] [Abstract][Full Text] [Related]
20. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
